Association between microchimerism and multiple sclerosis in Canadian twins

[1]  C. Willer,et al.  Maternal - offspring HLA-DRB1 compatibility in multiple sclerosis. , 2005, Tissue Antigens.

[2]  F. Terro,et al.  Monozygotic twins concordant for blood karyotype, but phenotypically discordant: A case of “mosaic chimerism” , 2005, American journal of medical genetics. Part A.

[3]  N. Risch,et al.  Parent-of-origin effect in multiple sclerosis: observations in half-siblings , 2004, The Lancet.

[4]  N. Risch,et al.  Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[5]  C. Willer,et al.  Microchimerism in autoimmunity and transplantation: potential relevance to multiple sclerosis , 2002, Journal of Neuroimmunology.

[6]  M. Klintschar,et al.  Evidence of fetal microchimerism in Hashimoto's thyroiditis. , 2001, The Journal of clinical endocrinology and metabolism.

[7]  K. Tsubota,et al.  Lack of evidence for an increased microchimerism in the circulation of patients with Sjögren's syndrome , 2001, Annals of the rheumatic diseases.

[8]  K. Kurasawa,et al.  Y chromosome microchimerism in rheumatic autoimmune disease , 2000, Annals of the rheumatic diseases.

[9]  H. Nakauchi,et al.  Microchimerism in Japanese women patients with systemic sclerosis , 1999, The Lancet.

[10]  D. Furst,et al.  Microchimerism of maternal origin persists into adult life. , 1999, The Journal of clinical investigation.

[11]  C. De Simone,et al.  Systemic sclerosis from autoimmunity to alloimmunity. , 1999, Southern medical journal.

[12]  Nelson Jl.  Microchimerism and the pathogenesis of systemic sclerosis. , 1998 .

[13]  S. Jimenez,et al.  Identification of fetal DNA and cells in skin lesions from women with systemic sclerosis. , 1998, The New England journal of medicine.

[14]  T K Lau,et al.  Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. , 1998, American journal of human genetics.

[15]  D. Furst,et al.  Microchimerism and HLA-compatible relationships of pregnancy in scleroderma , 1998, The Lancet.

[16]  J. Nelson,et al.  Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? , 1996, Arthritis and rheumatism.

[17]  G. Weil,et al.  Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[18]  L. Williamson,et al.  Transfusion-associated graft-versus-host disease and its prevention. , 1995, Blood reviews.

[19]  C. Rodeck,et al.  The time of appearance, and quantitation, of fetal DNA in the maternal circulation. , 1994, Annals of the New York Academy of Sciences.

[20]  Y. Lo.  Detection of minority nucleic acid populations by PCR , 1994, The Journal of pathology.

[21]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[22]  L. J. Cole,et al.  Effects of donor and host lymphoid and myeloid tissue injections in lethally x-irradiated mice treated with rat bone marrow. , 1958, Journal of the National Cancer Institute.

[23]  S. Jimenez,et al.  Fetal-maternal HLA compatibility confers susceptibility to systemic sclerosis , 1997, Immunogenetics.